Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome.

@article{akar2013AdverseIO,
  title={Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome.},
  author={Merih Kızıl Çakar and Zeynep Arzu Yeğin and Nuran Ahu Baysal and Sermin Altındal and Merve Pamukçuoğlu and B Ozbek Celik and Idil Yenicesu},
  journal={Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis},
  year={2013},
  volume={48 3},
  pages={397-401}
}
BACKGROUND Myelodysplastic syndrome (MDS) is characterized by peripheral cytopenias and dysplasia in one or more cell lines in the bone marrow. A significant proportion of patients require blood product support due to symptomatic anemia and/or thrombocytopenia during the course of their disease. This retrospective study was planned to evaluate the transfusion requirement of MDS patients and the role of ferritin in predicting transfusion requirement and response to treatment. METHODS We… CONTINUE READING